Clicky

ViroGates A/S(VIRO)

Description: ViroGates A/S, a medical technology company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.


Keywords: Medicine Cancer Disease Diabetes Medical Technology Healthcare Sector Hematology Intensive Care Medicine Heparin Plasminogen Activator Suparnostic Urokinase

Home Page: www.virogates.com

BanevAenget 13
Birkerød, 3460
Denmark
Phone: 45 21 13 13 36


Officers

Name Title
Mr. Jakob Knudsen Chief Exec. Officer
Dr. Jesper Eugen-Olsen Co-Founder & Chief Scientific Officer
Mr. Mark Christian Hvidberg da Silva Chief Financial Officer
Ms. May Britt Dyvelkov VP of Accounting
Mr. Thomas Krarup VP of Global Sales & Marketing

Exchange: CO

Country: DK

Currency: Danish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 7.494
Price-to-Sales TTM: 16.3833
IPO Date:
Fiscal Year End: December
Full Time Employees: 10
Back to stocks